25 Apr Blockbuster cancer drug developed by Bay Area biotech at center of drug-pricing ‘march-in’ rights controversy
Ron Leuty
San Francisco Business Times, 4/22/2022 ...
Other Media
07 Apr US universities fight potential Biden move on drug patents
Paul Basken
Times Higher Education, 4/7/2022
...
07 Apr $150K Prostate Cancer Drug Draws New Attention to ‘March-In’ Rights
Jennifer Henderson
MedPage Today, 4/6/2022 ...
31 Mar Biden’s looming prescription drug pricing dilemma
Caitlin Owens
Axios, 3/31/2022
Also published in Axios Vitals ...
25 Mar ‘March-in’ battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Zachary Brennan
Endpoints News, 3/25/2022 ...
25 Mar HHS Again Urged To Use March-In Rights To Cut Drug Costs
Britain Eakin
Law360, 3/24/2022 ...
24 Mar Pfizer Covid Pill Targeted in Bid for Biden to Spur Drug Access
Ian Lopez
Bloomberg Law, 3/24/2022 ...
21 Mar Warren Bid to Grab Pfizer Cancer Drug Patents Gets Stern Rebuke
Ian Lopez
Bloomberg Law, 3/18/2022
Also published in Bloomberg Government ...
22 Feb Here Is How Biden Can Attack High Drug Prices Without Congress
Johnathan Cohn
HuffPost, 2/20/2022
Also published in Yahoo News ...
17 Feb Stalled US drug price law drives experts to think outside box on lopsided costs
Michael Gibney
S&P Global Market Intelligence, 2/16/2022 ...